PAEIX | VTISX | PAEIX / VTISX | |
Total Expense Ratio | 1.07 | 0.05 | 2,277% |
Annual Report Gross Expense Ratio | 1.07 | 0.05 | 2,277% |
Fund Existence | 10 years | 9 years | - |
Gain YTD | 14.683 | 12.933 | 114% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 3000000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 24.1B | 470B | 5% |
Annual Yield % from dividends | 1.93 | 3.07 | 63% |
Returns for 1 year | 10.32 | 9.05 | 114% |
Returns for 3 years | 33.34 | 23.17 | 144% |
Returns for 5 years | 70.73 | 52.62 | 134% |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
JNK | 95.00 | -0.64 | -0.67% |
SPDR® Blmbg High Yield Bd ETF | |||
SABA | 8.65 | -0.06 | -0.69% |
Saba Capital Income & Opportunities Fund II | |||
APCB | 28.97 | -0.24 | -0.82% |
ActivePassive Core Bond ETF | |||
FTXH | 25.18 | -0.52 | -2.02% |
First Trust Nasdaq Pharmaceuticals ETF | |||
XHS | 97.83 | -2.77 | -2.75% |
SPDR® S&P Health Care Services ETF |